Postoperative surgical site infection (SSI) continues to be an important problem after orthopedic procedures, especially spine surgery. Reported incidences of surgical-site infection among patients who undergo spine surgery range from 2% to 6% and > 10% after instrumented fusions. Postoperative surgical-site infection is associated with an important rate of complications and cost. One of the methods to decrees the incidence of SSI is using intrawound local vancomycin. The current evidence supporting the use of intra wound vancomycin powder in surgical wounds is limited and controversial
